| 29 | NTRAOpen NTRA on Seeking Alpha in a new tab.90% of the way from the 52-week low to the 52-week high. | NateraHealthcare·Medical - Diagnostics & Research | 96 | 95Quality: 95th percentile | 97Momentum: 97th percentile | 16Growth: 16th percentile | 3Valuation: 3rd percentile | 45Expectations: 45th percentile | QQuality95Quality: 95th percentileMMomentum97Momentum: 97th percentileGGrowth16Growth: 16th percentileVValuation3Valuation: 3rd percentileEExpectations45Expectations: 45th percentile |
| 52 | GHOpen GH on Seeking Alpha in a new tab.89% of the way from the 52-week low to the 52-week high. | Guardant HealthHealthcare·Medical - Diagnostics & Research | 93 | –No data | 98Momentum: 98th percentile | 74Growth: 74th percentile | 2Valuation: 2nd percentile | 4Expectations: 4th percentile | QQuality–No dataMMomentum98Momentum: 98th percentileGGrowth74Growth: 74th percentileVValuation2Valuation: 2nd percentileEExpectations4Expectations: 4th percentile |
| 112 | RVTYOpen RVTY on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | RevvityHealthcare·Medical - Diagnostics & Research | 84 | 29Quality: 29th percentile | 96Momentum: 96th percentile | 14Growth: 14th percentile | 43Valuation: 43rd percentile | 79Expectations: 79th percentile | QQuality29Quality: 29th percentileMMomentum96Momentum: 96th percentileGGrowth14Growth: 14th percentileVValuation43Valuation: 43rd percentileEExpectations79Expectations: 79th percentile |
| 116 | CRLOpen CRL on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high. | Charles River Laboratories InternationalHealthcare·Medical - Diagnostics & Research | 84 | 33Quality: 33rd percentile | 95Momentum: 95th percentile | 15Growth: 15th percentile | 25Valuation: 25th percentile | 67Expectations: 67th percentile | QQuality33Quality: 33rd percentileMMomentum95Momentum: 95th percentileGGrowth15Growth: 15th percentileVValuation25Valuation: 25th percentileEExpectations67Expectations: 67th percentile |
| 119 | AOpen A on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | Agilent TechnologiesHealthcare·Medical - Diagnostics & Research | 83 | 47Quality: 47th percentile | 92Momentum: 92nd percentile | 56Growth: 56th percentile | 27Valuation: 27th percentile | 62Expectations: 62nd percentile | QQuality47Quality: 47th percentileMMomentum92Momentum: 92nd percentileGGrowth56Growth: 56th percentileVValuation27Valuation: 27th percentileEExpectations62Expectations: 62nd percentile |
| 121 | MEDPOpen MEDP on Seeking Alpha in a new tab.97% of the way from the 52-week low to the 52-week high. | MedpaceHealthcare·Medical - Diagnostics & Research | 83 | 55Quality: 55th percentile | 92Momentum: 92nd percentile | 48Growth: 48th percentile | 23Valuation: 23rd percentile | 63Expectations: 63rd percentile | QQuality55Quality: 55th percentileMMomentum92Momentum: 92nd percentileGGrowth48Growth: 48th percentileVValuation23Valuation: 23rd percentileEExpectations63Expectations: 63rd percentile |
| 132 | IQVOpen IQV on Seeking Alpha in a new tab.90% of the way from the 52-week low to the 52-week high. | IQVIAHealthcare·Medical - Diagnostics & Research | 81 | 25Quality: 25th percentile | 95Momentum: 95th percentile | 34Growth: 34th percentile | 53Valuation: 53rd percentile | 40Expectations: 40th percentile | QQuality25Quality: 25th percentileMMomentum95Momentum: 95th percentileGGrowth34Growth: 34th percentileVValuation53Valuation: 53rd percentileEExpectations40Expectations: 40th percentile |
| 165 | ILMNOpen ILMN on Seeking Alpha in a new tab.86% of the way from the 52-week low to the 52-week high. | IlluminaHealthcare·Medical - Diagnostics & Research | 77 | 26Quality: 26th percentile | 98Momentum: 98th percentile | 3Growth: 3rd percentile | 12Valuation: 12th percentile | 54Expectations: 54th percentile | QQuality26Quality: 26th percentileMMomentum98Momentum: 98th percentileGGrowth3Growth: 3rd percentileVValuation12Valuation: 12th percentileEExpectations54Expectations: 54th percentile |
| 174 | TMOOpen TMO on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | Thermo Fisher ScientificHealthcare·Medical - Diagnostics & Research | 75 | 36Quality: 36th percentile | 91Momentum: 91st percentile | 57Growth: 57th percentile | 37Valuation: 37th percentile | 42Expectations: 42nd percentile | QQuality36Quality: 36th percentileMMomentum91Momentum: 91st percentileGGrowth57Growth: 57th percentileVValuation37Valuation: 37th percentileEExpectations42Expectations: 42nd percentile |
| 231 | IDXXOpen IDXX on Seeking Alpha in a new tab.23% of the way from the 52-week low to the 52-week high. | IDEXX LaboratoriesHealthcare·Medical - Diagnostics & Research | 67 | 84Quality: 84th percentile | 28Momentum: 28th percentile | 59Growth: 59th percentile | 15Valuation: 15th percentile | 61Expectations: 61st percentile | QQuality84Quality: 84th percentileMMomentum28Momentum: 28th percentileGGrowth59Growth: 59th percentileVValuation15Valuation: 15th percentileEExpectations61Expectations: 61st percentile |
| 245 | MTDOpen MTD on Seeking Alpha in a new tab.96% of the way from the 52-week low to the 52-week high. | Mettler-Toledo InternationalHealthcare·Medical - Diagnostics & Research | 65 | –No data | 82Momentum: 82nd percentile | 37Growth: 37th percentile | 14Valuation: 14th percentile | 49Expectations: 49th percentile | QQuality–No dataMMomentum82Momentum: 82nd percentileGGrowth37Growth: 37th percentileVValuation14Valuation: 14th percentileEExpectations49Expectations: 49th percentile |
| 246 | LHOpen LH on Seeking Alpha in a new tab.90% of the way from the 52-week low to the 52-week high. | LabcorpHealthcare·Medical - Diagnostics & Research | 65 | 65Quality: 65th percentile | 80Momentum: 80th percentile | 23Growth: 23rd percentile | 67Valuation: 67th percentile | 42Expectations: 42nd percentile | QQuality65Quality: 65th percentileMMomentum80Momentum: 80th percentileGGrowth23Growth: 23rd percentileVValuation67Valuation: 67th percentileEExpectations42Expectations: 42nd percentile |
| 262 | WATOpen WAT on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | WatersHealthcare·Medical - Diagnostics & Research | 63 | 7Quality: 7th percentile | 92Momentum: 92nd percentile | 48Growth: 48th percentile | 21Valuation: 21st percentile | 23Expectations: 23rd percentile | QQuality7Quality: 7th percentileMMomentum92Momentum: 92nd percentileGGrowth48Growth: 48th percentileVValuation21Valuation: 21st percentileEExpectations23Expectations: 23rd percentile |
| 271 | DHROpen DHR on Seeking Alpha in a new tab.88% of the way from the 52-week low to the 52-week high. | DanaherHealthcare·Medical - Diagnostics & Research | 61 | 28Quality: 28th percentile | 86Momentum: 86th percentile | 58Growth: 58th percentile | 40Valuation: 40th percentile | 66Expectations: 66th percentile | QQuality28Quality: 28th percentileMMomentum86Momentum: 86th percentileGGrowth58Growth: 58th percentileVValuation40Valuation: 40th percentileEExpectations66Expectations: 66th percentile |
| 275 | DGXOpen DGX on Seeking Alpha in a new tab.93% of the way from the 52-week low to the 52-week high. | Quest DiagnosticsHealthcare·Medical - Diagnostics & Research | 61 | 53Quality: 53rd percentile | 82Momentum: 82nd percentile | 31Growth: 31st percentile | 74Valuation: 74th percentile | 43Expectations: 43rd percentile | QQuality53Quality: 53rd percentileMMomentum82Momentum: 82nd percentileGGrowth31Growth: 31st percentileVValuation74Valuation: 74th percentileEExpectations43Expectations: 43rd percentile |